[Revolution in treatment of renal carcinoma: molecular rational and clinical approach].
Escudier
Bernard
B
Gross-Goupil
Marine
M
D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000235:genetics; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011994:Recombinant Proteins / Q000627:therapeutic use
D004791:Enzyme Inhibitors; D007376:Interleukin-2; D011994:Recombinant Proteins; D007372:Interferons; D011505:Protein-Tyrosine Kinases